To gain further insight into the importance of IL-6 in macrophages as a key upstream factor driving CD59 up-regulation in pancreatic cancer cells, we neutralized IL-6 from the supernatants of the coculture system via a commercially available blocking antibody. The gene discussed is CD59; the disease is familial pancreatic carcinoma.